Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Raptor Pharmaceutical Corp (NASDAQ:RPTP)

12.83
Delayed Data
As of Aug 28
 +0.16 / +1.26%
Today’s Change
7.85
Today|||52-Week Range
16.28
+21.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.0B

Company Description

Raptor Pharmaceutical Corp. is a biopharmaceutical company, which focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. It has active development programs in cystinosis, a rare genetic disease, as well as other genetic and metabolic disorders. Raptor Pharmaceutical Corp was founded by Christopher M. Starr & Todd C. Zankel on September 29, 2009 and is headquartered in Novato, CA.

Contact Information

Raptor Pharmaceutical Corp.
7 Hamilton Landing
Novato California 94949
P:(415) 408-6200
Investor Relations:

Employees

Shareholders

Other institutional36.26%
Individual stakeholders22.18%
Mutual fund holders21.80%

Top Executives

Julie Anne SmithPresident, Chief Executive Officer & Director
Michael P. SmithCFO, Secretary, Treasurer & CAO
Todd C. ZankelChief Scientific Officer
Krishna R. PoluChief Medical Officer
Paul K. RossChief Compliance Officer & Vice President